• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    3/12/21 4:30:15 PM ET
    $DFPH
    Business Services
    Finance
    Get the next $DFPH alert in real time by email
    SC 13G 1 dfphealthcare_13gmar22021.htm SC 13G

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

     

     

    Under the Securities Exchange Act of 1934

    (Amendment No.)*

     

     

    DFP HEALTHCARE acquisitionS corp.

    (Name of Issuer)

     

    CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE

    (Title of Class of Securities)

    23343Q100

     

    (CUSIP Number)

     

    March 2, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:

     

    [   ] Rule 13d-1(b)

    [X] Rule 13d-1(c)

    [   ] Rule 13d-1(d)

     

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
     

     

     

    CUSIP No.  23343Q100
    (1) Names of Reporting Persons
      Park West Asset Management LLC  
    (2) Check the Appropriate Box if a Member of a Group (a) [    ]  
      (b) [    ]  
         
    (3) SEC Use Only
    (4) Citizenship or Place of Organization
      Delaware  
    Number of Shares Beneficially Owned By Each Reporting Person With
      (5) Sole Voting Power: 0*  
      (6) Shared Voting Power: 1,317,263*  
      (7) Sole Dispositive Power: 0*  
      (8) Shared Dispositive Power: 1,317,263*  
           
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
      1,317,263*  
    (10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions):
      [   ]  
    (11) Percent of Class Represented by Amount in Row (9)
      5.7%*  
    (12) Type of Reporting Person
      IA  
     

     * See Item 4 for additional information.

     

     

     

     

     
     

     

    CUSIP No.  23343Q100
    (1) Names of Reporting Persons
      Park West Investors Master Fund, Limited  
    (2) Check the Appropriate Box if a Member of a Group (a) [    ]  
      (b) [    ]  
         
    (3) SEC Use Only
    (4) Citizenship or Place of Organization
      Cayman Islands  
    Number of Shares Beneficially Owned By Each Reporting Person With
      (5) Sole Voting Power: 0*  
      (6) Shared Voting Power: 1,199,515*  
      (7) Sole Dispositive Power: 0*  
      (8) Shared Dispositive Power: 1,199,515*  
           
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
      1,199,515*  
    (10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions):
      [    ]  
    (11) Percent of Class Represented by Amount in Row (9)
      5.2%*  
    (12) Type of Reporting Person
      CO  
     

     * See Item 4 for additional information.

     

     

     

     
     

     

    CUSIP No.  23343Q100
    (1) Names of Reporting Persons
      Peter S. Park  
    (2) Check the Appropriate Box if a Member of a Group (a) [    ]  
      (b) [    ]  
         
    (3) SEC Use Only
    (4) Citizenship or Place of Organization
      United States of America  
    Number of Shares Beneficially Owned By Each Reporting Person With
      (5) Sole Voting Power: 0*  
      (6) Shared Voting Power: 1,317,263*  
      (7) Sole Dispositive Power: 0*  
      (8) Shared Dispositive Power: 1,317,263*  
           
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
      1,317,263*  
    (10) Check if the Aggregate Amount  in Row (9) Excludes Certain Shares (See Instructions):
      [    ]  
    (11) Percent of Class Represented by Amount in Row (9)
      5.7%*  
    (12) Type of Reporting Person
      IN  
     

     * See Item 4 for additional information.

     

     

     

     
     

     

    Item 1(a).  Name Of Issuer:  DFP Acquisitions Corp., a Delaware corporation (the “Company”)  
         
    Item 1(b).  Address of Issuer’s Principal Executive Offices:  
     

    780 Third Avenue, 37th Floor

    New York, New York 10017

     

     

    Item 2(a).  Name of Person Filing:  
     

    This report on Schedule 13G (this “Schedule 13G”) is being jointly filed by (i) Park West Asset Management LLC, a Delaware limited liability company (“PWAM”), (ii) Park West Investors Master Fund, Limited, a Cayman Islands exempted company (“PWIMF”) and (iii) Peter S. Park (“Mr. Park” and, collectively with PWAM and PWIMF, the “Reporting Persons”).

     

     
    Item 2(b).  Address of Principal Business Office or, if None, Residence:  
     

    The address for the Reporting Persons is:  900 Larkspur Landing Circle, Suite 165, Larkspur, California 94939.

     

     
    Item 2(c).  Citizenship:  
     

    PWAM is organized under the laws of the State of Delaware. PWIMF is a Cayman Islands exempted company. Mr. Park is a citizen of the United States.

     

     
    Item 2(d).  Title of Class of Securities:  
      Common Stock, $0.0001 par value per share (the “Common Stock”).  
    Item 2(e).  CUSIP No.:   
      23343Q100  
    Item 3.  If This Statement Is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the Person Filing is a:
      Not Applicable.

     

     

     

     

     

     
     

     

    Item 4.  Ownership:

    As reported in the cover pages to this report, the ownership information with respect to each of PWAM and Mr. Park is as follows:

     
         
      (a) Amount Beneficially Owned: 1,317,263*  
      (b) Percent of Class: 5.7%*  
      (c) Number of Shares as to which such person has:    
      (i) sole power to vote or to direct the vote: 0*  
      (ii) shared power to vote or to direct the vote: 1,317,263*  
      (iii) sole power to dispose or to direct the disposition of: 0*  
      (iv) shared power to dispose or to direct the disposition of: 1,317,263*  
               

     

    As reported in the cover pages to this report, the ownership information with respect to PWIMF is as follows:  
         
      (a) Amount Beneficially Owned: 1,199,515*  
      (b) Percent of Class: 5.2%*  
      (c) Number of Shares as to which such person has:    
      (i) sole power to vote or to direct the vote: 0*  
      (ii) shared power to vote or to direct the vote: 1,199,515*  
      (iii) sole power to dispose or to direct the disposition of: 0*  
      (iv) shared power to dispose or to direct the disposition of: 1,199,515*  

     

    * PWAM is the investment manager to PWIMF and Park West Partners International, Limited, a Cayman Islands exempted company (“PWPI,” and collectively with PWIMF, the “PW Funds”). Mr. Park, through one or more affiliated entities, is the controlling manager of PWAM.

     

    As of March 2, 2021, PWIMF held 1,142,862 shares of Common Stock and warrants (“Warrants”) to purchase common stock up to 56,653 shares of Common Stock and PWPI held 112,201 shares of Common Stock and Warrants to purchase up to 5,547 shares of Common Stock. As a result of the foregoing, PWAM and Mr. Park may be deemed to beneficially own the 1,255,063 shares of Common Stock and Warrants to purchase up to 62,200 shares of Common Stock held in the aggregate by the PW Funds.

     

    The reported beneficial ownership percentage is based upon 23,000,000 shares of Common Stock issued and outstanding as of November 13, 2020, based on information reported by the Company in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 13, 2020.

     

     

     

     
     

     

    Item 5.  Ownership of Five Percent or Less of a Class:
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  [   ]
    Item 6.  Ownership of More Than Five Percent on Behalf of Another Person:
      Not Applicable.
    Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
      Not Applicable.
    Item 8.  Identification and Classification of Members of the Group:
      Not Applicable.
    Item 9.  Notice of Dissolution of Group:
      Not Applicable.
    Item 10.  Certification:
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     
     
     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

      

    March 12, 2021  
         
      PARK WEST ASSET MANAGEMENT LLC  
         
         
      By: /s/ Grace Jimenez  
      Name: Grace Jimenez  
      Title: Chief Financial Officer  
             
      PARK WEST INVESTORS MASTER FUND, LIMITED    
           
      By:    Park West Asset Management LLC, its Investment Manager    
           
           
      By: /s/ Grace Jimenez  
      Name: Grace Jimenez    
     

    Title: Chief Financial Officer

     

       
             

     

      /s/ Peter S. Park  
      Peter S. Park  

     

       

     

     

    Attention: Intentional misstatements or omissions of fact constitute

    Federal criminal violations (See 18 U.S.C. 1001)

     

     

     

     

     

     

     

     

     
     
     

    Exhibit Index

     

    Exhibit

     

    1.     Joint Filing Agreement, dated as of March 12, 2021, by and between Park West Asset Management LLC, Park West Investors Master Fund, Limited and Peter S. Park.

     

     

     

     

     

      

     

     

       

       

     

     

     

     

     

     

     

     

    Get the next $DFPH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DFPH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DFPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider M33 Growth I L.P. claimed ownership of 15,256,383 shares

    3 - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:38:03 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 3: New insider Havencrest Healthcare Partners, L.P. claimed ownership of 15,662,794 shares

    3 - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:28:08 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 4: Sarin Ravi Yang was granted 4,109,771 shares (Amendment)

    4/A - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:15:17 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Oncology Institute Physician, Dr. John Khoury, Receives 40 Under 40 in Cancer Award

    This is the second year in a row a TOI physician was recognized The Oncology Institute (TOI) is proud to announce that Dr. John Khoury was recently awarded the "40 Under 40 in Cancer" award by the Association for Value-Based Cancer Care. This is the second year in a row a TOI physician was recognized for this honor. Dr. Omkar Marathe was selected for the distinction in 2020. "It's an honor to be part of such a distinguished list of young oncology professionals and leaders who work very hard to improve the lives of those affected by cancer," said Dr. Khoury. Dr. John Khoury is a triple board-certified physician who joined The Oncology Institute in 2020. He completed his residency and fell

    11/9/21 9:15:00 AM ET
    $DFPH
    Business Services
    Finance

    DFP Healthcare Acquisitions Corp. Announces Special Meeting Date to Approve Proposed Business Combination with The Oncology Institute

    Special Meeting of Stockholders Scheduled for November 12, 2021 DFP Healthcare Acquisitions Corp. ("DFP") (NASDAQ:DFPH) announced today that it has scheduled the special meeting of its stockholders (the "Special Meeting") for November 12, 2021 at 10:00 a.m., Eastern Time, to approve the proposed business combination (the "Business Combination") with The Oncology Institute ("TOI" or the "Company"), the U.S. market leader in providing value-based oncology care. DFP also announced that it has filed its definitive proxy statement/prospectus for the Special Meeting and has commenced mailing the definitive proxy statement/prospectus to its stockholders of record as of September 23, 2021, the re

    10/22/21 4:05:00 PM ET
    $DFPH
    Business Services
    Finance

    The Oncology Institute of Hope and Innovation (TOI) Expands to San Diego County

    Two state-of-the-art clinics opening in Vista and Chula Vista with a third in Hillcrest slated for later this year The Oncology Institute of Hope and Innovation (TOI) began seeing patients this week at two new locations in Vista and Chula Vista, marking the community-based oncology provider's entry into San Diego County. A third location in Hillcrest is slated to open in the fall. Founded in 2007, TOI is a multi-state cancer care practice dedicated to healing and empowering patients through compassion, innovation, and state-of-the-art medical care. TOI is the largest value-based oncology practice in the U.S., taking accountability for both the quality outcomes as well as the medical costs

    8/4/21 12:05:00 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    SEC Filings

    View All

    DFP Healthcare Acquisitions Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (Amendment)

    8-K/A - Oncology Institute, Inc. (0001799191) (Filer)

    11/22/21 5:18:03 PM ET
    $DFPH
    Business Services
    Finance

    DFP Healthcare Acquisitions Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Registrant’s Certifying Accountant, Changes in Control of Registrant, Leadership Update, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Other Events, Financial Statements and Exhibits

    8-K - Oncology Institute, Inc. (0001799191) (Filer)

    11/18/21 5:29:51 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 25-NSE filed by DFP Healthcare Acquisitions Corp.

    25-NSE - DFP HEALTHCARE ACQUISITIONS CORP. (0001799191) (Subject)

    11/12/21 4:20:20 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:41:54 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:25:01 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:19:36 PM ET
    $DFPH
    Business Services
    Finance